CurrentEndo coverage · page 20 of 55

Diabetes, Obesity and Metabolism

Briefs 761–800 of 2,200 CurrentEndo has covered from this journal, newest publication first

Latest from Diabetes, Obesity and Metabolism

All coverage, newest first

Diabetes Obes Metab25 Nov 2025
Feasibility study of a combined insulin‐delivery and glucose sensor system worn over 7 days in persons with type 1 diabetes
Research articleTechnology
Diabetes Obes Metab24 Nov 2025
Diabetes self‐management education and its association with hospital admissions and premature mortality: A scoping review and meta‐analysis
Meta-analysisT2D & other
Diabetes Obes Metab24 Nov 2025
A nationwide 12‐month observatory of automated insulin delivery shows improved glucose control, sustained adoption, and reduced acute severe events
Cohort study
Diabetes Obes Metab24 Nov 2025
The effect of nutraceutical interventions on reproductive health outcomes in women with polycystic ovary syndrome: A systematic review and meta‐analysis
Meta-analysisReproductive endocrine
Diabetes Obes Metab24 Nov 2025
Effects of liraglutide treatment for 18 days on metabolic parameters, regional body composition and the myostatin–activin–follistatin– IGF ‐1 axis: Results from an exploratory, randomized, placebo‐controlled, crossover study
Randomized controlled trialT2D & other
Diabetes Obes Metab24 Nov 2025
New‐onset prediabetes/diabetes worsens overall survival in patients with cancer: A real‐world retrospective cohort study
Cohort studyT2D & other
Diabetes Obes Metab20 Nov 2025
Efficacy and safety of bi‐weekly cofrogliptin treatment replacing daily dipeptidyl peptidase‐4 inhibitors in Chinese patients with type 2 diabetes mellitus: A multicenter, open‐label, randomized controlled phase 2 trial
Randomized controlled trialT2D & other
Diabetes Obes Metab19 Nov 2025
Efficacy and safety of glucagon‐like peptide 1 receptor agonists across all health outcomes in type 2 diabetes: An umbrella review and evidence map of randomised controlled trials
Meta-analysisT2D & other
Diabetes Obes Metab19 Nov 2025
Long‐term glycemic exposure, glycemic control stability and incident calcific aortic valve disease: A prospective cohort study
Cohort studyT2D & other
Diabetes Obes Metab18 Nov 2025
Effects of hypoxic training interventions on cardiometabolic health of adults with overweight and obesity: A systematic review and meta‐analysis
Meta-analysisObesity
Diabetes Obes Metab18 Nov 2025
The value and impact of weight reduction from the perspective of people with type 2 diabetes in the United States
Cross-sectional studyT2D & other
Diabetes Obes Metab18 Nov 2025
Despite lower haemoglobin A1c with second‐generation automated insulin delivery systems, mental burden remains high for all adults with type 1 diabetes: A BETTER registry analysis
Cross-sectional studyTechnology
Diabetes Obes Metab17 Nov 2025
Real‐world evaluation of clinical outcomes in Dutch patients with type 2 diabetes treated with oral semaglutide: A retrospective, observational cohort study using the PHARMO data network
Cohort studyT2D & other
Diabetes Obes Metab17 Nov 2025
Nomogram‐based prediction of hypoglycemia risk in elderly community‐dwelling patients with type 2 diabetes: Development and validation in a multicentre real‐world cohort
Diagnostic or prognostic studyT2D & other
Diabetes Obes Metab14 Nov 2025
Lobeglitazone improves glycaemic control as add‐on therapy to empagliflozin plus metformin in patients with type 2 diabetes mellitus: A double‐blind, randomised, placebo‐controlled trial
Randomized controlled trialT2D & other
Diabetes Obes Metab14 Nov 2025
Prescribing of glucose‐lowering medication to adults with type 2 diabetes by severe mental illness status in Scotland: A cohort study
Cohort studyT2D & other
Diabetes Obes Metab12 Nov 2025
Ethnic differences in the comparative effectiveness of second‐line type 2 diabetes medications in preventing cardiovascular disease
Cohort studyT2D & other
Diabetes Obes Metab12 Nov 2025
Estimating the risk of cardiovascular outcomes and all‐cause mortality in individuals with type 2 diabetes: Validation of the UKPDS outcomes model using TECOS and EXSCEL data
Diagnostic or prognostic studyT2D & other
Diabetes Obes Metab12 Nov 2025
Initiation of sodium‐glucose cotransporter‐2 inhibitors and the risk of infection‐related hospitalisations: A population‐based cohort study
Cohort studyT2D & other
Diabetes Obes Metab11 Nov 2025
Baseline characteristics in the SYNCHRONIZE ™‐2 randomized phase 3 trial of survodutide, a glucagon receptor/ GLP ‐1 receptor dual agonist, for obesity in people with type 2 diabetes
Randomized controlled trialT2D & other
Diabetes Obes Metab11 Nov 2025
Medical events and costs associated with metabolic bariatric surgery among adults with type 2 diabetes: A retrospective, matched cohort study
Cohort studyObesity
Diabetes Obes Metab10 Nov 2025
Biweekly dosing of efsubaglutide alfa maintains glycaemic and continuous glucose monitoring control in type 2 diabetes: A randomised multicentre trial
Randomized controlled trialT2D & other
Diabetes Obes Metab10 Nov 2025
Effects of SGLT2 inhibitors across the spectrum of albuminuria in cardiovascular–kidney–metabolic conditions: A pooled analysis of randomised trials
Meta-analysisComplications
Diabetes Obes Metab10 Nov 2025
The global burden of early‐onset type 2 diabetes (1990–2050): An age–period–cohort analysis of incidence, disparities, and projections
Secondary analysisT2D & other
Diabetes Obes Metab10 Nov 2025
Sodium glucose co‐transporter 2 inhibitors versus dipeptidyl peptidase‐4 inhibitors and the risk of ventricular arrhythmia among patients with type 2 diabetes: A population‐based cohort study
Cohort studyT2D & other
Diabetes Obes Metab10 Nov 2025
Early subcutaneous basal insulin with intravenous insulin infusion for diabetic ketoacidosis management: A systematic review and meta‐analysis of randomised controlled trials
Meta-analysisT1D
Diabetes Obes Metab10 Nov 2025
The association between glycaemic control, normal weight and long‐term macrovascular outcomes in people with type 2 diabetes in China: A retrospective study
Cohort studyT2D & other
Diabetes Obes Metab10 Nov 2025
Newly defined clinical obesity versus body mass index ‐defined obesity: Differential risks of overall death and adverse events in a population‐based cohort
Cohort studyObesity
Diabetes Obes Metab10 Nov 2025
Anabolic androgenic steroid use and risk of diabetes mellitus in males
Cohort studyT2D & other
Diabetes Obes Metab5 Nov 2025
Association between metabolic syndrome and risk of cardiovascular disease among postmenopausal women: A cohort study
Cohort studyReproductive endocrine
Diabetes Obes Metab5 Nov 2025
Efficacy and safety of switching to ezetimibe 10 mg/rosuvastatin 2.5 mg in Korean patients with type 2 diabetes mellitus and dyslipidaemia: A multicentre, prospective study ( EROICA study)
Cohort studyT2D & other
Diabetes Obes Metab5 Nov 2025
Acute inflammation amplifies the diabetogenic effect of excess adiposity: Evidence from a real‐life, prospective cohort
Cohort studyObesity
Diabetes Obes Metab5 Nov 2025
A novel framework to assess the prevention value of a health intervention
Research articleObesity
Diabetes Obes Metab5 Nov 2025
Associations between gestational diabetes and cardiovascular disease largely operate independently of postpartum causal pathways: A population‐based cohort study in England
Cohort studyDiabetes in pregnancy
Diabetes Obes Metab5 Nov 2025
Safety and efficacy of hybrid closed‐loop insulin pump therapy in adolescents and adults with type 1 diabetes in China
Research articleTechnology
Diabetes Obes Metab5 Nov 2025
Associations between obesity indices and cognitive function: Evidence from a middle‐aged observational and Mendelian randomisation study
Cross-sectional studyObesity
Diabetes Obes Metab4 Nov 2025
Associations of general and central obesity with risk of premature mortality among Chinese adults: A nationwide prospective cohort study
Cohort studyObesity
Diabetes Obes Metab4 Nov 2025
Improved health‐related quality of life with tirzepatide versus semaglutide in adults with obesity or overweight from the SURMOUNT ‐5 trial
Secondary analysisObesity
Diabetes Obes Metab4 Nov 2025
One‐year usage patterns of SGLT ‐2 inhibitors and GLP ‐1 receptor agonists in individuals with type 2 diabetes in a real‐world population
Cohort studyT2D & other
Diabetes Obes Metab4 Nov 2025
Survodutide for treatment of obesity: Baseline characteristics of participants in a randomized, double‐blind, placebo‐controlled, phase 3 trial ( SYNCHRONIZE ™‐1)
Randomized controlled trialObesity

All 2,200 Briefs in ExploreShowing Briefs 761–800 of 2,200, newest first